Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lymphomas”

1,366 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,366 results

Not applicableStudy completedNCT02192333
What this trial is testing

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Who this might be right for
Breast CarcinomaCancer SurvivorDepression+10 more
Fred Hutchinson Cancer Center 390
Testing effectiveness (Phase 2)Looking for participantsNCT05463263
What this trial is testing

STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Who this might be right for
Lymphoma, B-CellLymphoma, T-Cell
Step Pharma, SAS 180
Early research (Phase 1)Study completedNCT01051635
What this trial is testing

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00057811
What this trial is testing

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more
Children's Oncology Group 97
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT02113800
What this trial is testing

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

Who this might be right for
Poorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more
AIO-Studien-gGmbH
Testing effectiveness (Phase 2)Ended earlyNCT04082936
What this trial is testing

Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin LymphomaFollicular LymphomaDLBCL+2 more
IGM Biosciences, Inc. 97
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390852
What this trial is testing

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT06792734
What this trial is testing

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Who this might be right for
Lymphoma, B-Cell
Bantam Pharmaceuticals 24
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Not applicableStudy completedNCT00552825
What this trial is testing

Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaSolid Tumors,+2 more
Sheba Medical Center 35
Early research (Phase 1)Ended earlyNCT03786926
What this trial is testing

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

Who this might be right for
Lymphoma
Hutchmed 53
Early research (Phase 1)Study completedNCT03763149
What this trial is testing

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas

Who this might be right for
Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd. 20
Early research (Phase 1)Study completedNCT01445535
What this trial is testing

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

Who this might be right for
T-Cell Peripheral LymphomaGamma Delta Hepatosplenic T-Cell LymphomaSubcutaneous Panniculitis-Like T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT06067347
What this trial is testing

A Global Study of the PETAL Consortium

Who this might be right for
T-Cell and NK-Cell Neoplasm
Massachusetts General Hospital 1,200
Not applicableUnknownNCT04698616
What this trial is testing

Lean Body Mass and Side Effects in Patients With Lymphoma

Who this might be right for
Malignant Lymphoma
Jens Rikardt Andersen 141
Not applicableLooking for participantsNCT05231135
What this trial is testing

A Registry Study on HIV-related Lymphoma

Who this might be right for
AIDS Related LymphomaHIV Related Lymphoma
Rotkreuzklinikum München gGmbH 300
Early research (Phase 1)Study completedNCT03205176
What this trial is testing

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Who this might be right for
Malignant Solid TumorsLymphomaOvarian Cancer+3 more
AstraZeneca 49
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Load More Results
40